I have said similar things about the milestone payments previously but got shouted down on here by the fan club …. perhaps AstraZeneca are undertaking combo phase1/phase 2 trial to get around having to pay an additional milestone payment because they can still classify it as a phase 1 trial for the same drug ?
I think your final paragraph sums up what could have transpired …. Rest assured the 120+ years of commercial experience at HQ won’t tell us if you comments are on the money
NCT04214093...at last we get the full picture, page-8
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $38.11K | 389.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20455 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 38876 | 3 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |